<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68999">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02143440</url>
  </required_header>
  <id_info>
    <org_study_id>2012273</org_study_id>
    <nct_id>NCT02143440</nct_id>
  </id_info>
  <brief_title>The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes</brief_title>
  <official_title>The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the daily dose of insulin in newly diagnosed Chinese type 2 diabetic patients
      who use the continuous subcutaneous insulin infusion (CSII) as the initial therapy.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>When the glucose level decreased to about 10 mmol/L</measure>
    <time_frame>72-96 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Type 2 Diabetes.</condition>
  <arm_group>
    <arm_group_label>Newly diagnosed type 2 patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The initial assessment of daily insulin dose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>The initial assessment of daily insulin dose.</intervention_name>
    <arm_group_label>Newly diagnosed type 2 patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All participants with type 2 diabetes, diagnosed by World Health Organization criteria,
        were recruited from outpatient of the Endocrinology Department in Shanghai Renji Hospital.

        Exclusion Criteria:

        Patients who had a history of coronary heart disease, abnormal renal function, active
        liver disease, chronic metabolic acidosis (including diabetic ketoacidosis), or severe
        chronic gastrointestinal disease.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <lastchanged_date>May 17, 2014</lastchanged_date>
  <firstreceived_date>May 17, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
